What's in Universidad de Antioquia's pipeline?

Universidad de Antioquia has 7 drugs in our index: 2 marketed, 0 filed, 3 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with Universidad de Antioquia's portfolio?

Top competitors by shared drug class: Ajou University School of Medicine, Alameda Health System, American University of Beirut Medical Center, Anemia Working Group Romania, Asker & Baerum Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/universidad-de-antioquia.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Universidad de Antioquia — Portfolio Competitive Intelligence Brief

Universidad de Antioquia pipeline: 2 marketed, 0 filed, 3 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 3 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
PCA Ketamine	PCA Ketamine	marketed	NMDA receptor antagonist	NMDA receptor	Anesthesia
Articaine / EPINEPHrine Cartridge	Articaine / EPINEPHrine Cartridge	marketed	Local anesthetic with vasopressor	Voltage-gated sodium channels (articaine); alpha-1 and beta-1 adrenergic receptors (epinephrine)	Anesthesia / Dentistry
Unfractioned heparin	Unfractioned heparin	phase 3	Anticoagulant		Cardiovascular
Arnica Tincture	Arnica Tincture	phase 3	Herbal extract / Natural product		Dermatology / Wound healing / Musculoskeletal
Continuous sciatic nerve block	Continuous sciatic nerve block	phase 3			Pain Management / Regional Anesthesia

Therapeutic area mix

Anesthesia · 1
Anesthesia / Dentistry · 1
Cardiovascular · 1
Dermatology / Wound healing / Musculoskeletal · 1
Pain Management / Regional Anesthesia · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ajou University School of Medicine · 1 shared drug class
Alameda Health System · 1 shared drug class
American University of Beirut Medical Center · 1 shared drug class
Anemia Working Group Romania · 1 shared drug class
Asker & Baerum Hospital · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
AstraZeneca · 1 shared drug class
Acacia Pharma Ltd · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Universidad de Antioquia:

Cite this brief

Drug Landscape (2026). Universidad de Antioquia — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universidad-de-antioquia. Accessed 2026-05-16.